Medipal seeks to diversify amid falling drug margins
Japan’s largest drug wholesaler is seeking to boost profit, excluding extraordinary items, to ¥100 billion by March 2027 from ¥65 billion in the latest fiscal year.
Tomas Kauer - News Moderator 
Japan’s largest drug wholesaler is seeking to boost profit, excluding extraordinary items, to ¥100 billion by March 2027 from ¥65 billion in the latest fiscal year.
